1. Home
  2. Products
  3. Customized ADCs
  4. TPBG
  5. Anti-TPBG ( V422C)-Mc-MMAD ADC

Anti-TPBG ( V422C)-Mc-MMAD ADC (CAT#: ADC-W-161)

This ADC product is comprised of an anti-TPBG monoclonal antibody (V422C) conjugated via a Mc linker to MMAD. The MMAD is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAD binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.

  • ADC Target
  • ADC Antibody
  • ADC Linker
  • ADC payload drug
  • Name
  • TPBG
  • Alternative Names
  • M6P1; TPBGAG; WAIF1; TPBG oncofetal antigen; TPBG oncotrophoblast glycoprotein; wnt-activated inhibitory factor 1; TPBG oncofetal trophoblast glycoprotein;
  • Target Entrez Gene ID
  • 7162
  • Overview
  • This gene encodes a leucine-rich transmembrane glycoprotein that may be involved in cell adhesion. The encoded protein is an oncofetal antigen that is specific to trophoblast cells. In adults this protein is highly expressed in many tumor cells and is associated with poor clinical outcome in numerous cancers. Alternate splicing in the 5 UTR results in multiple transcript variants that encode the same protein.
  • Overview
  • Engineered Anti-TPBG antibody, V422C
  • Generic name
  • V422C
  • Species Reactivity
  • Human
  • Name
  • Mc (maleimidocaproyl)
  • Description
  • Noncleavable linkers, is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.
  • Name
  • MMAD (monomethyl auristatin D)
  • Description
  • Derived from Auristatin,are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.

For Research Use Only. NOT FOR CLINICAL USE.

Published Data

+ Submit Publications

Submit a review or a question

Scientific Resources

Customer Reviews and FAQs

There are currently no Customer reviews or questions for ADC-W-161. Click the button above to contact us or submit your feedback about this product.

Quick Links

Other Products

Same Target Same Linker Same Payload
CAT# Product Name Linker Payload
ADC-W-312 Anti-TPBG (clone A1)-hydroxyl amino PEG-MMAD ADC hydroxyl amino PEG linker MMAD (monomethyl auristatin D)
ADC-W-007 Anti-TPBG (clone A3)-VC-MMAE ADC VC (valine-citrulline) MMAE (Monomethyl auristatin E)
ADC-W-164 Anti-TPBG (E380C)-VC-MMAD ADC VC (valine-citrulline) MMAD (monomethyl auristatin D)
ADC-W-163 Anti-TPBG (K392C)-Mc-MMAD ADC Mc (maleimidocaproyl) MMAD (monomethyl auristatin D)
ADC-W-537 Anti-TPBG-Mc-MMAF ADC Mc (maleimidocaproyl) MMAF (Monomethyl auristatin F)
CAT# Product Name Linker Payload
ADC-W-478 Anti-ENPP3-Mc-MMAF ADC Mc (maleimidocaproyl) MMAF (Monomethyl auristatin F)
ADC-W-518 Anti-TM4SF1 ( clone 2A7A)-Mc-LP2 ADC Mc (maleimidocaproyl) LP2 (chemical name mc-3377)
ADC-W-491 Anti-TNFRSF17-Mc-MMAF ADC Mc (maleimidocaproyl) MMAF (Monomethyl auristatin F)
ADC-W-485 Anti-EphA2 (clone 1C1)-Mc-MMAF ADC Mc (maleimidocaproyl) MMAF (Monomethyl auristatin F)
ADC-W-2606 Anti-ITGB3 (Tadocizumab)-MC-MMAF ADC MC (maleimidocaproyl) MMAF
CAT# Product Name Linker Payload
ADC-W-408 Anti-ERBB2 (Trastuzumab)-MMAD ADC Non-Cleavable hydroxyl amino PEG linker MMAD (monomethyl auristatin D)
ADC-W-312 Anti-TPBG (clone A1)-hydroxyl amino PEG-MMAD ADC hydroxyl amino PEG linker MMAD (monomethyl auristatin D)
ADC-W-290 Anti-TACSTD2 (clone 7E6)-AcLys-VC-PABC-MMAD ADC AcLys-VC- PABC (Acetyl-lysine-valine-citrulline-p-aminobenzyloxycarbonyl) MMAD (monomethyl auristatin D)
ADC-W-568 Anti-TACSTD2 (clone C16)-VC-MMAD ADC VC (valine-citrulline) MMAD (monomethyl auristatin D)
ADC-W-413 Anti-ERBB2 (Trastuzumab)-hydroxyl amino PEG linker-MMAD (monomethyl auristatin D) ADC hydroxyl amino PEG linker MMAD (monomethyl auristatin D)

Online Inquiry

Name:
*Phone:
*E-mail Address:
*Products or Services Interested:
Company/Institution
Project Description:

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.